APO Research

APO RESEARCH · REPORT

Hemodialysis

In this report, Hemodialysis denotes dialysis equipment segmented by machine type and application, rather than the revenue of providing dialysis treatment.

Product & engineering

Understand the product.

Hemodialysis is used for hemodialysis equipment. Referred to hemodialysis, also known as the popular saying artificial kidney, dialysis is a blood purification technology. The principle of using semi-permeable membrane, by diffusion, convection, and the body of harmful metabolic wastes and excess electrolytes too much out of the body, to achieve the purpose of purifying the blood and suck up water and electrolyte and acid-base balance correction purposes. According to the different treatment methods, divided into intermittent hemodialysis and continuous hemodialysis treatment. In addition to chronic renal failure replacement therapy used, but also widely used in different causes of acute renal failure, multiple organ failure, severe trauma, acute necrotizing pancreatitis, hyperkalemia, hypernatremia, acute alcoholism, etc. . Hemodialysis can reduce the symptoms and prolong survival time, and it is the effective measures to rescue of acute and chronic renal failure.

Technical reading

Selected research

Market Outlook & Growth Opportunities

Global Hemodialysis Market Outlook and Growth Opportunities 2026

Market perspective

Hemodialysis is used for hemodialysis equipment. Referred to hemodialysis, also known as the popular saying artificial kidney, dialysis is a blood purification technology. The principle of using semi-permeable membrane, by diffusion, convection, and the body of harmful metabolic wastes and excess electrolytes too much out of the body, to achieve the purpose of purifying the blood and suck up water and electrolyte and acid-base balance correction purposes. According to the different treatment methods, divided into intermittent hemodialysis and continuous hemodialysis treatment. In addition to chronic renal failure replacement therapy used, but also widely used in different causes of acute renal failure, multiple organ failure, severe trauma, acute necrotizing pancreatitis, hyperkalemia, hypernatremia, acute alcoholism, etc. . Hemodialysis can reduce the symptoms and prolong survival time, and it is the effective measures to rescue of acute and chronic renal failure.

Europe is the largest Hemodialysis market with about 42% market share. US is follower, accounting for about 29% market share.

The key players are Fresenius, Baxter & Gambro, B.Braum, Nikkiso, Toray, Nipro, Bellco, Asahi Kasei, WEGO, Shanwaishan, Jihua etc. Top 3 companies occupied about 81% market share.

Read the full market overview

This report provides an overview of the global Hemodialysis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemodialysis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemodialysis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemodialysis market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemodialysis Segment by Company

Fresenius

Baxter & Gambro

B.Braum

Nikkiso

Toray

Nipro

Bellco

Asahi Kasei

WEGO

Shanwaishan

Jihua

Hemodialysis Segment by Type

Hemodialysis Machine (HD)

Hemodiafiltration Machine (HF)

Bedside Hemodiafiltration Machines (Bedside Machines or Bedside Blood Filtration)

Hemodialysis Segment by Application

Acute Renal Failure

Chronic Renal Failure

Acute Drug Poisoning or Poison

Others

Hemodialysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemodialysis status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hemodialysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemodialysis significant trends, drivers, influence factors in global and regions.

6. To analyze Hemodialysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemodialysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemodialysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemodialysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemodialysis market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemodialysis industry.

Chapter 3: Detailed analysis of Hemodialysis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hemodialysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hemodialysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemodialysis Industry Trends Table 2. Hemodialysis Industry Drivers Table 3. Hemodialysis Industry Opportunities and Challenges Table 4. Hemodialysis Industry Restraints Table 5. Global Hemodialysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemodialysis Revenue Share by Company (2021-2026) Table 7. Global Hemodialysis Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Hemodialysis Sales Volume Share by Company (2021-2026) Table 9. Global Hemodialysis Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Hemodialysis Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hemodialysis Key Company Manufacturing Base & Headquarters Table 12. Global Hemodialysis Company, Product Type & Application Table 13. Global Hemodialysis Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemodialysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hemodialysis Machine (HD) Table 18. Significant Companies of Hemodiafiltration Machine (HF) Table 19. Significant Companies of Bedside Hemodiafiltration Machines (Bedside Machines or Bedside Blood Filtration) Table 20. Global Hemodialysis Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Hemodialysis Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Hemodialysis Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Hemodialysis Sales Volume Share by Type (2021-2026) Table 24. Global Hemodialysis Sales Volume Share by Type (2027-2032) Table 25. Global Hemodialysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Hemodialysis Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Hemodialysis Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Hemodialysis Sales Value Share by Type (2021-2026) Table 29. Global Hemodialysis Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Acute Renal Failure Table 31. Significant Companies of Chronic Renal Failure Table 32. Significant Companies of Acute Drug Poisoning or Poison Table 33. Significant Companies of Others Table 34. Global Hemodialysis Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Hemodialysis Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Hemodialysis Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Hemodialysis Sales Volume Share by Application (2021-2026) Table 38. Global Hemodialysis Sales Volume Share by Application (2027-2032) Table 39. Global Hemodialysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Hemodialysis Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Hemodialysis Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Hemodialysis Sales Value Share by Application (2021-2026) Table 43. Global Hemodialysis Sales Value Share by Application (2027-2032) Table 44. Global Hemodialysis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Hemodialysis Sales by Region (2021-2026) & (K Units) Table 46. Global Hemodialysis Sales Market Share by Region (2021-2026) Table 47. Global Hemodialysis Sales by Region (2027-2032) & (K Units) Table 48. Global Hemodialysis Sales Market Share by Region (2027-2032) Table 49. Global Hemodialysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Hemodialysis Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Hemodialysis Sales Value Share by Region (2021-2026) Table 52. Global Hemodialysis Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Hemodialysis Sales Value Share by Region (2027-2032) Table 54. Global Hemodialysis Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Hemodialysis Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Hemodialysis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Hemodialysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hemodialysis Sales by Country (2021-2026) & (K Units) Table 59. Global Hemodialysis Sales Market Share by Country (2021-2026) Table 60. Global Hemodialysis Sales by Country (2027-2032) & (K Units) Table 61. Global Hemodialysis Sales Market Share by Country (2027-2032) Table 62. Global Hemodialysis Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Hemodialysis Sales Value Market Share by Country (2021-2026) Table 64. Global Hemodialysis Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Hemodialysis Sales Value Market Share by Country (2027-2032) Table 66. Fresenius Company Information Table 67. Fresenius Business Overview Table 68. Fresenius Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Fresenius Hemodialysis Product Portfolio Table 70. Fresenius Recent Development Table 71. Baxter & Gambro Company Information Table 72. Baxter & Gambro Business Overview Table 73. Baxter & Gambro Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Baxter & Gambro Hemodialysis Product Portfolio Table 75. Baxter & Gambro Recent Development Table 76. B.Braum Company Information Table 77. B.Braum Business Overview Table 78. B.Braum Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. B.Braum Hemodialysis Product Portfolio Table 80. B.Braum Recent Development Table 81. Nikkiso Company Information Table 82. Nikkiso Business Overview Table 83. Nikkiso Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Nikkiso Hemodialysis Product Portfolio Table 85. Nikkiso Recent Development Table 86. Toray Company Information Table 87. Toray Business Overview Table 88. Toray Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Toray Hemodialysis Product Portfolio Table 90. Toray Recent Development Table 91. Nipro Company Information Table 92. Nipro Business Overview Table 93. Nipro Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Nipro Hemodialysis Product Portfolio Table 95. Nipro Recent Development Table 96. Bellco Company Information Table 97. Bellco Business Overview Table 98. Bellco Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Bellco Hemodialysis Product Portfolio Table 100. Bellco Recent Development Table 101. Asahi Kasei Company Information Table 102. Asahi Kasei Business Overview Table 103. Asahi Kasei Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Asahi Kasei Hemodialysis Product Portfolio Table 105. Asahi Kasei Recent Development Table 106. WEGO Company Information Table 107. WEGO Business Overview Table 108. WEGO Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. WEGO Hemodialysis Product Portfolio Table 110. WEGO Recent Development Table 111. Shanwaishan Company Information Table 112. Shanwaishan Business Overview Table 113. Shanwaishan Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Shanwaishan Hemodialysis Product Portfolio Table 115. Shanwaishan Recent Development Table 116. Jihua Company Information Table 117. Jihua Business Overview Table 118. Jihua Hemodialysis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Jihua Hemodialysis Product Portfolio Table 120. Jihua Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Hemodialysis Distributors List Table 124. Hemodialysis Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Hemodialysis Product Image Figure 2. Global Hemodialysis Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hemodialysis Sales (2021-2032) & (K Units) Figure 5. Global Hemodialysis Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Hemodialysis Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hemodialysis Machine (HD) Image Figure 10. Hemodiafiltration Machine (HF) Image Figure 11. Bedside Hemodiafiltration Machines (Bedside Machines or Bedside Blood Filtration) Image Figure 12. Global Hemodialysis Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Hemodialysis Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Hemodialysis Sales Volume Share by Type (2021-2032) Figure 15. Global Hemodialysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Hemodialysis Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Hemodialysis Sales Value Share by Type (2021-2032) Figure 18. Acute Renal Failure Image Figure 19. Chronic Renal Failure Image Figure 20. Acute Drug Poisoning or Poison Image Figure 21. Others Image Figure 22. Global Hemodialysis Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Hemodialysis Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Hemodialysis Sales Volume Share by Application (2021-2032) Figure 25. Global Hemodialysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Hemodialysis Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Hemodialysis Sales Value Share by Application (2021-2032) Figure 28. Global Hemodialysis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Hemodialysis Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Hemodialysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Hemodialysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 33. North America Hemodialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Hemodialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Hemodialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 39. South America Hemodialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Hemodialysis Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Hemodialysis Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Hemodialysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Hemodialysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Hemodialysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Hemodialysis Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Hemodialysis Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Hemodialysis Machine (HD)
  • Hemodiafiltration Machine (HF)
  • Bedside Hemodiafiltration Machines (Bedside Machines or Bedside Blood Filtration)
Applications
  • Acute Renal Failure
  • Chronic Renal Failure
  • Acute Drug Poisoning or Poison
  • Others
Companies covered
  • Fresenius
  • Baxter & Gambro
  • B.Braum
  • Nikkiso
  • Toray
  • Nipro
  • Bellco
  • Asahi Kasei
  • WEGO
  • Shanwaishan
  • Jihua

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemodialysis Sales Value (2021-2032)
  4. 1.2.2 Global Hemodialysis Sales Volume (2021-2032)
  5. 1.2.3 Global Hemodialysis Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hemodialysis Market Dynamics
  1. 2.1 Hemodialysis Industry Trends
  2. 2.2 Hemodialysis Industry Drivers
  3. 2.3 Hemodialysis Industry Opportunities and Challenges
  4. 2.4 Hemodialysis Industry Restraints
3 Hemodialysis Market by Company
  1. 3.1 Global Hemodialysis Company Revenue Ranking in 2025
  2. 3.2 Global Hemodialysis Revenue by Company (2021-2026)
  3. 3.3 Global Hemodialysis Sales Volume by Company (2021-2026)
  4. 3.4 Global Hemodialysis Average Price by Company (2021-2026)
  5. 3.5 Global Hemodialysis Company Ranking (2024-2026)
  6. 3.6 Global Hemodialysis Company Manufacturing Base and Headquarters
  7. 3.7 Global Hemodialysis Company Product Type and Application
  8. 3.8 Global Hemodialysis Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hemodialysis Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hemodialysis Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hemodialysis Market by Type
  1. 4.1 Hemodialysis Type Introduction
  2. 4.1.1 Hemodialysis Machine (HD)
  3. 4.1.2 Hemodiafiltration Machine (HF)
  4. 4.1.3 Bedside Hemodiafiltration Machines (Bedside Machines or Bedside Blood Filtration)
  5. 4.2 Global Hemodialysis Sales Volume by Type
  6. 4.2.1 Global Hemodialysis Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemodialysis Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Hemodialysis Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Hemodialysis Sales Value by Type
  10. 4.3.1 Global Hemodialysis Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemodialysis Sales Value by Type (2021-2032)
  12. 4.3.3 Global Hemodialysis Sales Value Share by Type (2021-2032)
5 Hemodialysis Market by Application
  1. 5.1 Hemodialysis Application Introduction
  2. 5.1.1 Acute Renal Failure
  3. 5.1.2 Chronic Renal Failure
  4. 5.1.3 Acute Drug Poisoning or Poison
  5. 5.1.4 Others
  6. 5.2 Global Hemodialysis Sales Volume by Application
  7. 5.2.1 Global Hemodialysis Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hemodialysis Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Hemodialysis Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Hemodialysis Sales Value by Application
  11. 5.3.1 Global Hemodialysis Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Hemodialysis Sales Value by Application (2021-2032)
  13. 5.3.3 Global Hemodialysis Sales Value Share by Application (2021-2032)
6 Hemodialysis Regional Sales and Value Analysis
  1. 6.1 Global Hemodialysis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemodialysis Sales by Region (2021-2032)
  3. 6.2.1 Global Hemodialysis Sales by Region: 2021-2026
  4. 6.2.2 Global Hemodialysis Sales by Region (2027-2032)
  5. 6.3 Global Hemodialysis Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hemodialysis Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hemodialysis Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hemodialysis Sales Value by Region (2027-2032)
  9. 6.5 Global Hemodialysis Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hemodialysis Sales Value (2021-2032)
  12. 6.6.2 North America Hemodialysis Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hemodialysis Sales Value (2021-2032)
  15. 6.7.2 Europe Hemodialysis Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hemodialysis Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hemodialysis Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hemodialysis Sales Value (2021-2032)
  21. 6.9.2 South America Hemodialysis Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hemodialysis Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hemodialysis Sales Value Share by Country, 2025 VS 2032
7 Hemodialysis Country-level Sales and Value Analysis
  1. 7.1 Global Hemodialysis Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemodialysis Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hemodialysis Sales by Country (2021-2032)
  4. 7.3.1 Global Hemodialysis Sales by Country (2021-2026)
  5. 7.3.2 Global Hemodialysis Sales by Country (2027-2032)
  6. 7.4 Global Hemodialysis Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hemodialysis Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hemodialysis Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hemodialysis Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hemodialysis Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hemodialysis Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hemodialysis Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hemodialysis Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hemodialysis Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hemodialysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hemodialysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hemodialysis Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hemodialysis Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hemodialysis Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hemodialysis Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hemodialysis Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hemodialysis Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hemodialysis Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hemodialysis Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hemodialysis Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hemodialysis Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hemodialysis Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hemodialysis Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hemodialysis Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hemodialysis Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hemodialysis Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hemodialysis Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hemodialysis Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hemodialysis Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hemodialysis Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hemodialysis Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hemodialysis Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hemodialysis Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hemodialysis Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hemodialysis Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hemodialysis Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hemodialysis Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hemodialysis Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hemodialysis Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hemodialysis Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hemodialysis Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hemodialysis Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hemodialysis Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hemodialysis Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hemodialysis Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hemodialysis Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hemodialysis Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hemodialysis Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hemodialysis Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hemodialysis Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hemodialysis Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hemodialysis Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hemodialysis Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hemodialysis Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hemodialysis Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hemodialysis Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hemodialysis Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hemodialysis Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hemodialysis Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hemodialysis Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hemodialysis Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hemodialysis Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hemodialysis Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hemodialysis Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hemodialysis Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hemodialysis Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hemodialysis Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hemodialysis Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hemodialysis Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hemodialysis Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hemodialysis Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hemodialysis Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hemodialysis Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hemodialysis Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hemodialysis Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hemodialysis Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hemodialysis Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hemodialysis Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hemodialysis Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hemodialysis Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hemodialysis Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hemodialysis Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hemodialysis Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hemodialysis Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hemodialysis Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hemodialysis Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hemodialysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Fresenius
  2. 8.1.1 Fresenius Company Information
  3. 8.1.2 Fresenius Business Overview
  4. 8.1.3 Fresenius Hemodialysis Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Fresenius Hemodialysis Product Portfolio
  6. 8.1.5 Fresenius Recent Developments
  7. 8.2 Baxter & Gambro
  8. 8.2.1 Baxter & Gambro Company Information
  9. 8.2.2 Baxter & Gambro Business Overview
  10. 8.2.3 Baxter & Gambro Hemodialysis Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baxter & Gambro Hemodialysis Product Portfolio
  12. 8.2.5 Baxter & Gambro Recent Developments
  13. 8.3 B.Braum
  14. 8.3.1 B.Braum Company Information
  15. 8.3.2 B.Braum Business Overview
  16. 8.3.3 B.Braum Hemodialysis Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B.Braum Hemodialysis Product Portfolio
  18. 8.3.5 B.Braum Recent Developments
  19. 8.4 Nikkiso
  20. 8.4.1 Nikkiso Company Information
  21. 8.4.2 Nikkiso Business Overview
  22. 8.4.3 Nikkiso Hemodialysis Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nikkiso Hemodialysis Product Portfolio
  24. 8.4.5 Nikkiso Recent Developments
  25. 8.5 Toray
  26. 8.5.1 Toray Company Information
  27. 8.5.2 Toray Business Overview
  28. 8.5.3 Toray Hemodialysis Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Toray Hemodialysis Product Portfolio
  30. 8.5.5 Toray Recent Developments
  31. 8.6 Nipro
  32. 8.6.1 Nipro Company Information
  33. 8.6.2 Nipro Business Overview
  34. 8.6.3 Nipro Hemodialysis Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nipro Hemodialysis Product Portfolio
  36. 8.6.5 Nipro Recent Developments
  37. 8.7 Bellco
  38. 8.7.1 Bellco Company Information
  39. 8.7.2 Bellco Business Overview
  40. 8.7.3 Bellco Hemodialysis Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bellco Hemodialysis Product Portfolio
  42. 8.7.5 Bellco Recent Developments
  43. 8.8 Asahi Kasei
  44. 8.8.1 Asahi Kasei Company Information
  45. 8.8.2 Asahi Kasei Business Overview
  46. 8.8.3 Asahi Kasei Hemodialysis Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Asahi Kasei Hemodialysis Product Portfolio
  48. 8.8.5 Asahi Kasei Recent Developments
  49. 8.9 WEGO
  50. 8.9.1 WEGO Company Information
  51. 8.9.2 WEGO Business Overview
  52. 8.9.3 WEGO Hemodialysis Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 WEGO Hemodialysis Product Portfolio
  54. 8.9.5 WEGO Recent Developments
  55. 8.10 Shanwaishan
  56. 8.10.1 Shanwaishan Company Information
  57. 8.10.2 Shanwaishan Business Overview
  58. 8.10.3 Shanwaishan Hemodialysis Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanwaishan Hemodialysis Product Portfolio
  60. 8.10.5 Shanwaishan Recent Developments
  61. 8.11 Jihua
  62. 8.11.1 Jihua Company Information
  63. 8.11.2 Jihua Business Overview
  64. 8.11.3 Jihua Hemodialysis Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jihua Hemodialysis Product Portfolio
  66. 8.11.5 Jihua Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemodialysis Value Chain Analysis
  2. 9.1.1 Hemodialysis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemodialysis Sales Mode & Process
  6. 9.2 Hemodialysis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemodialysis Distributors
  9. 9.2.3 Hemodialysis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research